financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Coursera Insider Sold Shares Worth $595,505, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Coursera Insider Sold Shares Worth $595,505, According to a Recent SEC Filing
Apr 22, 2024 3:03 PM

05:32 PM EDT, 04/22/2024 (MT Newswires) -- Jeffrey Nacey Maggioncalda, Director, President & CEO, on April 18, 2024, sold 50,000 shares in Coursera ( COUR ) for $595,505. Following the Form 4 filing with the SEC, Maggioncalda has control over a total of 2,177,496 shares of the company, with 2,177,496 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1651562/000095017024046528/xslF345X03/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AbbVie trims annual profit forecast after expected $2.7 billion R&D hit
AbbVie trims annual profit forecast after expected $2.7 billion R&D hit
Oct 3, 2025
Oct 3 (Reuters) - Drugmaker AbbVie said on Friday it has lowered its annual profit forecast, after a flagging an expected $2.7 billion charge related to in-process research and development (IPR&D) expenses in the third quarter. Shares of the North Chicago-based company were down nearly 1% at $232.0 in extended trade. AbbVie ( ABBV ) said in a regulatory filing...
 AbbVie trims annual profit forecast after expected $2.7 billion R&D hit
AbbVie trims annual profit forecast after expected $2.7 billion R&D hit
Oct 3, 2025
(Reuters) -Drugmaker AbbVie said on Friday it has lowered its annual profit forecast, after a flagging an expected $2.7 billion charge related to in-process research and development (IPR&D) expenses in the third quarter. Shares of the North Chicago-based company were down nearly 1% at $232.0 in extended trade. AbbVie ( ABBV ) said in a regulatory filing that such expenses...
 BRIEF-Intelligent Group Says Unit Has Entered Into Subscription Agreement To Invest In Fine Glory Holdings
BRIEF-Intelligent Group Says Unit Has Entered Into Subscription Agreement To Invest In Fine Glory Holdings
Oct 3, 2025
Oct 3 (Reuters) - Intelligent Group Ltd ( INTJ ): * INTELLIGENT GROUP LTD ( INTJ ): UNIT HAS ENTERED INTO SUBSCRIPTION AGREEMENT TO INVEST IN FINE GLORY HOLDINGS LTD * INTELLIGENT GROUP LTD ( INTJ ): IJL WILL ACQUIRE MINORITY STAKE IN FINE GLORY VALUED AT $20 MILLION BY SUBSCRIBING TO CLASS B NON-VOTING SHARES Source text: Further company...
 Arcutis Biotherapeutics Insider Sold Shares Worth $884,649, According to a Recent SEC Filing
Arcutis Biotherapeutics Insider Sold Shares Worth $884,649, According to a Recent SEC Filing
Oct 3, 2025
05:15 PM EDT, 10/03/2025 (MT Newswires) -- Todd Watanabe, Director, President and Chief Executive Officer, on October 01, 2025, sold 45,000 shares in Arcutis Biotherapeutics ( ARQT ) for $884,649. Following the Form 4 filing with the SEC, Watanabe has control over a total of 1,079,574 common shares of the company, with 846,440 shares held directly and 233,134 controlled indirectly....
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved